140 related articles for article (PubMed ID: 7019325)
1. Partial characterization of a lymphoid cell line (Reh) product with leukocyte inhibitory factor (LIF) activity.
Rocklin RE; Blidy A; Butler J; Minowada J
J Immunol; 1981 Aug; 127(2):534-9. PubMed ID: 7019325
[No Abstract] [Full Text] [Related]
2. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells.
Center DM; Cruikshank W
J Immunol; 1982 Jun; 128(6):2563-8. PubMed ID: 7042840
[No Abstract] [Full Text] [Related]
3. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients].
Puppo F; Corsini G; Mangini P; Armani U; Piana A
Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916
[No Abstract] [Full Text] [Related]
4. Production and characterization of supernatants with high titers of human leukocyte inhibitory factor (LIF).
McCoy JL; Braatz JA; Ames RS; Herberman RB
J Immunol; 1980 Jun; 124(6):2786-93. PubMed ID: 6989906
[No Abstract] [Full Text] [Related]
5. [Leukocyte migration inhibition test for functional evaluation of the T-lymphocyte population].
Bilynskaia KhZ; Loginskiĭ VE
Lab Delo; 1980; (5):316-7. PubMed ID: 6156295
[No Abstract] [Full Text] [Related]
6. [Stimulation of phagocytic function by factors inhibiting leukocyte and macrophage migration in humans].
Gankovskaia LV; Tskhovrebova AZ; Gvozdeva NA; Koval'chuk LV; Cheredeev AN
Biull Eksp Biol Med; 1986 Aug; 102(8):210-3. PubMed ID: 3527300
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine effect upon the erythrocyte antibody uptake by human monocytes.
Sipka S; Kávai M; Teichmann F; Boldogh I; Szegedi G
Haematologia (Budap); 1987; 20(2):73-8. PubMed ID: 3115874
[TBL] [Abstract][Full Text] [Related]
8. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions.
Pettersson T; Welin MG; Weber TH
J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387
[TBL] [Abstract][Full Text] [Related]
9. "In vitro" and "in vivo" leukocyte migration inhibitory factor production in acute infectious mononucleosis patients.
Bertotto A; Gentili F; Stagni G; Zucchetti Z; Vaccaro R
Boll Ist Sieroter Milan; 1983 Jul; 62(3):281-6. PubMed ID: 6357231
[TBL] [Abstract][Full Text] [Related]
10. Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. I. Effect of various metabolic inhibitors.
Bendtzen K; Mahoney R; Rocklin RE
Clin Immunol Immunopathol; 1981 Feb; 18(2):212-20. PubMed ID: 7008991
[No Abstract] [Full Text] [Related]
11. [Stimulation of human and bovine lymphocytes by various Streptococcus species].
Hahn G; Heide P; Gross WL
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):214-20. PubMed ID: 6359774
[TBL] [Abstract][Full Text] [Related]
12. Production of interferon and other lymphokines during murine tumour growth. I. Lymphokines in cell--free fluid of rat Zajdela ascites hepatoma.
Zschiesche W; Fahlbusch B; Schumann I; Lackovic V; Borecký L
Acta Virol; 1980 Jan; 24(1):37-44. PubMed ID: 6155776
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
Bendtzen K
Scand J Immunol; 1977; 6(1-2):126-31. PubMed ID: 322258
[TBL] [Abstract][Full Text] [Related]
14. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
Rocklin RE
J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
[TBL] [Abstract][Full Text] [Related]
15. Identification and initial characterization of a nonspecific suppressor factor (macrophage-SF) produced by soluble immune response suppressor (SIRS)-treated macrophages.
Aune TM; Pierce CW
J Immunol; 1981 Nov; 127(5):1828-33. PubMed ID: 7197699
[No Abstract] [Full Text] [Related]
16. Human lymphocytes produce both leukocyte migration inhibition (LIF) and stimulation (MStF) factors after mitogen, alloantigens or antigen activation.
Favila-Castillo L; Méndez-Samperio P; Cortés-Castillo MA; Sánchez-Ortega A
Rev Latinoam Microbiol; 1988; 30(2):111-5. PubMed ID: 3064229
[No Abstract] [Full Text] [Related]
17. Certain characteristics of human lymphocyte migration inhibitory factors (LyMIF) and the effect of ampicillin on their appearance in unstimulated and PHA-stimulated cultures.
Skopińska-Rózewska E; Madaliński W; Lukasik R
Acta Physiol Pol; 1983; 34(3):353-67. PubMed ID: 6372368
[TBL] [Abstract][Full Text] [Related]
18. Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. II. Effects of cyclic nucleotides.
Bendtzen K; Mahoney R; Rocklin RE
Clin Immunol Immunopathol; 1981 Feb; 18(2):221-9. PubMed ID: 6258834
[No Abstract] [Full Text] [Related]
19. Use of cryopreserved lymphocytes for the indirect leukocyte migration inhibition assay.
Szigeti R; Stevens D; Ernberg I; Klein G; Masucci MG; Svedmyr E; Klein E
J Immunol Methods; 1981; 46(3):369-74. PubMed ID: 6273472
[TBL] [Abstract][Full Text] [Related]
20. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
